1. Gut barrier dysfunction, endotoxemia and inflammatory response in STEMI patients and effect of primary PCI.
- Author
-
Oikonomou I, Papageorgiou A, de Lastic AL, Moulias A, Georgopoulou GA, Mouzaki A, Koufou EE, Tsigkas G, Gogos C, Davlouros P, and Assimakopoulos SF
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Cytokines blood, Prospective Studies, Endotoxins blood, Zonula Occludens-1 Protein metabolism, ST Elevation Myocardial Infarction blood, ST Elevation Myocardial Infarction surgery, ST Elevation Myocardial Infarction physiopathology, Endotoxemia blood, Endotoxemia therapy, Percutaneous Coronary Intervention, Inflammation blood
- Abstract
Background: Gut-derived bacterial and endotoxin translocation induce systemic inflammation, which exerts a pivotal pathogenetic role in all phases of atherosclerosis., Objectives: To investigate prospectively the gut barrier function, endotoxin translocation and inflammatory response in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary artery intervention (PPCI)., Methods: Twenty-seven patients with STEMI that underwent successful PPCI were subjected to peripheral blood sampling at 3-time points; before PPCI (day0), 24 h (day1) and 96 h (day4) after PPCI and were compared with 20 chronic coronary syndrome (CCS) patients and 11 healthy controls. Serum ZO-1, I-FABP and endotoxin concentrations were determined by ELISA. Concentrations of cytokines IL-1β, -6, -8, -10 and TNF-α were determined by flow cytometry., Results: Patients with STEMI before PPCI (day0) had increased serum ZO-1 and endotoxin, both at significantly higher levels compared to CCS patients. STEMI induced also significant increases of the cytokines IL-6, -8 and -10. After PPCI, a significant improvement of gut barrier integrity (ZO-1) and endotoxemia was observed from the first day. At day4 post PPCI, systemic endotoxin and cytokines IL-6, -8 and -10 levels were reduced to control levels. Serum ZO-1 levels were positively correlated with systemic IL-10 concentrations (r = 0.471)., Conclusion: STEMI is associated with gut barrier dysfunction, systemic endotoxemia and inflammatory response, which improve rapidly following successful PPCI., Competing Interests: Declaration of competing interest The following authors declare that they have no competing interests: Ioanna Oikonomou, MD, Angeliki Papageorgiou, MD, Anne-Lise de Lastic, MD, PhD, Athanasios Moulias, MD, PhD, Georgia-Andriana Georgopoulou, MD, Athanasia Mouzaki, MD, PhD, Eleni-Evangelia Koufou, MD, Grigorios Tsigkas, MD, PhD, Charalambos Gogos, MD, PhD, Periklis Davlouros, MD, PhD, Stelios F. Assimakopoulos, MD, PhD, (Copyright © 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF